FGF23 and chronic kidney disease: Using a combination of in vitro techniques, 2 distinct models of CKD, and gain-of-function and loss-of function genetic mouse models, we further identify FGF23-FGFR4 activation as a potential mechanism of cardiac mitochondrial dysfunction and metabolic remodeling in CKD.